Chris Viehbacher Sanofi was the mystery “Party A” that engaged in a bidding war with Biogen for the $7.3 billion buyout of Reata Pharmaceuticals, according to a Bloomberg News report, citing unnamed sources.
The French Big Pharma bid for Reata first,…
Click here to view original post
